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Background: Despite the increasing pervasiveness of mobile computational technologies, knowledge about
psychiatric patients’ preferences regarding the design and utility of mobile applications is very poor. This paper
reports on a pilot-study that involved 120 psychiatric patients in the development of a mobile application (app)
that is being used for data entry into the Signature Project data bank at the Institut universitaire en santé mentale de
Montréal (IUSMM), Canada. Participants were invited to comment on the ‘look and feel’ of the Signature App. Their
input also extended the procedures for data collection. These suggestions may contribute to increased mental
health literacy and empowerment of persons with mental illness receiving services at the IUSMM.
Methods: Participants were recruited to fill out a questionnaire on a tablet computer while waiting at the
Emergency Room (ER, n = 40), Psychotic Disorders outpatient clinic (n = 40) or Anxiety and Mood Disorders
outpatient clinic (n = 40) of IUSMM. Nine patients from each of these sub-groups participated in a focus group to
review the results and to discuss how the design and use of the Signature App could be improved to better meet
the needs of patients.
Results: This study (n = 120) indicated that psychiatric patients are clearly capable of using a tablet computer to fill
out questionnaires for quantitative data entry, and that they enjoyed this experience. Results from the focus groups
(n = 27) highlight that the app could also be used by patients to communicate some personal and contextual
qualitative information. This would support a holistic and person-centered approach, especially at the ER where
people acutely need to describe their recent history and receive emotional support.
Conclusions: This pilot-study has confirmed the necessity of involving patients not only in the testing of a new
mobile application, but also as active contributors in the entire research and development process of a
person-centered information and communication technology infrastructure. The input of participants was essential
in designing the Signature Project computational procedure and making use of the app a positive and
empowering experience. Participants also gave critical feedback remarks that went beyond the initial scope of the
pilot-study, for example they suggested the addition of a client-clinician component.
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New products are usually designed to match targeted
users’ preferences and capacities by involving them in the
research and development process (R&D) [1]. In recent
years, mobile applications (apps) have become part of
daily life for many, and they have also entered the medical
field [2]. For example, apps can be used by patients who
would like to quit smoking [3] or to lose weight [4], but
more often apps are designed to be used by professionals
[5]. This may explain why Mosa et al. recently observed
that in the scientific literature there is “low coverage” of
smart phones apps intended for patients [6] and hence,
even less of their eventual contribution to an app R&D
process. Of the 14 articles related to mobile applications
dedicated to patients’ use, their systematic review captured
2 papers reporting on apps to be used by psychiatric pa-
tients, both regarding self-monitoring of substance use
[7,8]. Neither of these papers discussed patient contribu-
tions to the R&D processes for these apps. Therefore, we
still know very little about what the nature of the input
from psychiatric patients would be to the R&D of an app
to be used by their peers.
In May 2010 the Centre de recherché de l’Institut
univesitaire en santé mentale de Montréal (CRIUSMM),
Canada, aligned itself with the “four P’s” of research,
according to the National Institute of Mental Health: 1) in-
creasing the capacity to Predict who is at risk for develo-
ping disease; 2) developing interventions that Pre-empt the
disease process; 3) using knowledge about individual bio-
logical, environmental and social factors for Personalized
interventions; and 4) ensuring that clinical research in-
volves Participation from the diversity of people involved
in health care, including patients [9]. This paper mainly
focuses on the latter “P”, that is on the active participation
of IUSMM psychiatric service-users in the R&D of an app
imbedded in an innovative computational architecture
meant to support more personalized psychiatric interven-
tions (third “P”).
A pilot-study was undertaken at IUSMM as a prelimi-
nary step in the implementation of a comprehensive data-
bank, known as the Signature Project. This endeavour, a
first in the field of psychiatric research, aims to embrace
use of the “four P’s” by collecting a wide array of bio-
logical, psychological and social data concerning the 6000
in- and out-patients that receive IUSMM psychiatric care
and services and by involving them as active participants.
For instance, the psychological and social data sets will be
electronically collected by patients filling out a series of
questionnaires on a tablet computer with an app (Signature
App). To make the Signature App as user-friendly as pos-
sible, the pilot-study involved 120 participants who were
asked to fill out a questionnaire on a tablet and to com-
ment on this experience. The preliminary results were
discussed in focus groups by 27 participants who reflectedand gave their insights on how to make this human-
computer interaction useful for patients as well as for
researchers and clinicians.
In November 2012, the Signature Project officially began
to collect psychological and social data from IUSMM
patients e.g.: [10-14]. In accordance with the increasing
emphasis on the role of patients in developing and eva-
luating services [15,16], influencing research priorities
[17,18], and actively contributing to information and com-
munication technology (ICT) systems design [1,19], this
paper reports on the research process and findings, in re-
gard to improving the design and utility of the Signature
Project computational procedure and its app suite. The
pilot project aimed to answer two questions regarding the
participants’ experience using an app: (1) Are psychiatric
patients able to use the mobile application technology?
and (2) How can the mobile application be improved to
better meet patients’ needs?
Study design
To assess how psychiatric patients can use an app on a
tablet computer to fill out questionnaires and how this
data collection procedure can be improved to better meet
their needs, 120 psychiatric patients of IUSMM were
recruited from October 2010 to January 2011 to complete
a questionnaire with a beta version of the Signature App,
and to participate in an individual debriefing interview.
Participating patients were recruited in specialized out-
patient clinics: Anxiety and Mood disorders clinic, and
Psychotic disorders clinic, where patients receive services
in accordance with these specific diagnostics. Participants
at the ER were not recruited on the basis of their diagnos-
tics. Participants were thus selected in three sub-groups:
Anxiety and mood disorders (AMD, n = 40), Psychotic dis-
orders (PD, n = 40), and Emergency Room (ER, n = 40).
These volumes were chosen in order to generate as many
insights as possible and were representative samples of pa-
tients treated in the corresponding IUSMM sites. The total
volume of 120 patients was in line with comparable studies
for broader psychiatric populations [20], and for specific
subpopulations such as inpatients suffering from schizo-
phrenia [21-23]. Patients who agreed to participate in the
individual testing and debriefing interview were also in-
vited to participate in a focus group. Participation and
acceptance ratios are presented in Table 1.
The inclusion criteria were that the participants had to
be treated at the testing site, that they had sufficient
mental capacities to allow informed consent, and that
they were legally able to consent for themselves. At each
site, a Research Nurse (RN) was introduced by the cli-
nical team to the patients, unless the chief psychiatrist
considered that a patient was not able to participate at
that time. The clinical team stopped approaching pa-
tients when the target number of participants was
Table 1 Participation and acceptance ratios
AMD PD ER ALL
1 Approached for individual testing and interviews 47 55 51 153
2 Recruited for individual testing and interviews 40 40 40 120
3 Accepted to participate in a focus group 19 28 21 68
4 Participated in a focus group 9 9 9 27
5 Ratio of participation for individual testing and interviews 85% 73% 79% 78%
(Line 2/Line 1)
6 Ratio of acceptance to participate in a focus group 48% 70% 53% 57%
(Line 3/Line 2)
Table 2 Appendix A of the research protocol
Themes Observations





4) Not very attentive
5) Not attentive at all
Feasibility of electronic
signature
1) Could sign easily
2) Had some difficulty to sign
3) Could not sign/did not want to sign on
the app
Understanding the app 1) Had no difficulty in understanding
2) Did not understand the basic concepts
3) Could not navigate from question to
question
4) Had some difficulty reading the
instructions/questions
Using the app 1) Had no difficulty in using the app
2) Wanted to press on a button but pressed
another one
3) Tried to press but the software did not
detect
4) Left an answer that did not seem to be
wanted answer
Got frustrated 1) No
2) Yes (if yes, why?)
Completed 1) Yes
2) No (if no, why?)
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two weeks (10 days) at the AMD and PD sites, and four
weeks (20 days) at the ER.
Staff in charge at each site identified a liaison clinician,
whose responsibility included coordinating the referral of
potential participants to the RN. The RN then approached
the referred participant and briefly introduced the study.
The RN explained that the device would be used to play a
video introducing the study and its ethical aspects,
followed by an electronic consent form for the partici-
pant’s digital signature. Finally, an electronic version of
the Beck Depression Inventory was administered on the
handheld device. The Beck Depression Inventory (BDI)
is a 21-question self-report inventory [24] that is widely
used for measuring the severity of depression. IUSMM
Institutional Review Board approval for this pilot-study
was granted on September 1st, 2010.
Methods
Six main steps were followed in this pilot-study: (1) identi-
fying and approaching potential participants, (2) introdu-
cing the project to them, (3) obtaining their consent, (4)
administering the BDI questionnaire with the Signature
App, (5) debriefing with each participant, and (6) con-
ducting focus groups. Focus groups were held to further
explore the user experience with the Signature App and
more broadly to explore ways of enhancing the utility of
this computational procedure for patients. The RN was
present with the participating patients at all times, and
recorded her observations with a template (Table 2:
Appendix A of the research protocol). This study was
carried out in compliance with the Helsinki Declaration
and the Institutional Review Board of IUSMM gave ap-
proval (reference number: 2010–012).
If a patient agreed to view the video, the RN handed the
tablet to him or her and started the video. The video lasted
approximately 5 minutes, with the Principal Investigator
(PI) (on-screen) describing the project’s goal and the
ethical aspects of the study that participants must under-
stand before consenting. This step was included to validate
the feasibility of explaining the study by video in order tofoster informed consent, as patients do not always tho-
roughly read a multi-page consent form. The presence of
the RN throughout the consent process ensured that the
participant could, at any time, request further explanation
or verbally refuse to participate.
For those who accepted and signed the form, the app
automatically transitioned to the BDI questionnaire. For
each question, four choices were displayed on the app.
The participant simply had to touch the choice that best
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the next question.
Once the questionnaire was completed, the RN con-
ducted a short debriefing session with the participant to
elicit his/her feedback on their experience of completing
the questionnaire, and his/her ideas for improving the
intervention. Each session of individual data collection
lasted approximately 30 minutes. At the end of the indi-
vidual session, the participant was invited to attend a focus
group to further explore his/her experience with the app.
Three focus groups were held, one for each sub-group in-
volved in this study. In each of these subsequent meetings,
a facilitator guided 9 participants in a two-hour discussion
of their experiences and feelings about their use of the app
and their preferences or opinions about how to improve
the “look and feel” of the app and the usefulness of the
overall computational procedure. To foster discussion, the
facilitator asked the participants to comment on the re-
sults and themes covered by the individual debriefing
sessions (Appendix A of the research protocol used by
the RN). Those themes are:
1. Attention in viewing the video;
2. Feasibility of electronic signature;
3. Understanding the app;




7. Discussing the results.
No names of individual debriefing session participants
were mentioned and focus group participants were asked
to maintain the confidentiality of other focus group
participants.
Results and discussion
For conversational purposes in focus groups with lay
psychiatric patients unfamiliar with specialized statistical
terminologies (e.g.: SD), it was necessary to present the
results in the most accessible manner to combine quan-
titative and qualitative data sets. It was thus decided to
use percentages in order to foster discussion, as they are
presented in Table 3.
Attention in viewing the video
The level of attention in viewing the video was scored by
the RN for each participant on a Lickert scale: 5) extremely
attentive, 4) very attentive, 3) attentive with occasional
distraction, 2) not very attentive with long periods of
distraction, and 1) not attentive/constantly distracted. The
scores were summed, for a maximum total of 200 for each
group of 40 participants (40X5) and the result was dividedby 2 to become a percentage. Rankings for other themes
were calculated in a similar fashion.
In focus groups, participants said that they were not sur-
prised by the high level of attention in viewing the video
(80%). They suggested that it was normal that the level of
attention was lower at the ER due to a person’s typically
high level of distress in that situation. Others suggested
that the variability in attention might be due to the fact
that for some people, it is more convenient to read be-
cause reading can be done at one’s own pace, versus hea-
ring a video. Nevertheless, the overall very high attention
level indicates that presenting a consent form through
video with a multimedia app helps the viewer to stay
focused (e.g.: of 40 PD participants, 21 were checked
'extremely attentive' and 13 'very attentive'; 34/40). While
waiting at an outpatient clinic, this type of activity is also
seen as a positive distraction: it is different and more
empowering than simply reading a magazine, for example.
Participants suggested that the presence of such a tablet
computer could be an incentive to some people to stick to
their appointment and that it could be used not only to
capture some data but also to enhance mental health
literacy by offering accurate and useful information on
mental health and mental illness management.
Feasibility of electronic signature
Electronically signing the consent form was deemed to
be feasible, but many holder participants found that it
was too different from signing on paper with a pen, and
that both signatures did not really resemble. Several par-
ticipants questioned whether or not such a signature
was as legally binding as a penned signature. Also, since
participants had to receive a paper copy of their consent
form and terms of participation, the RN had to use
paper sheets anyway to give the participant a copy and
to leave another copy for the hospital record. Thus par-
ticipants in focus groups recommended use of pen and
paper for signing the consent form.
Understanding and using the app
A small number of participants had some difficulty un-
derstanding the Signature App, mainly due to the small
size of the font, and received assistance from the RN.
Only a few participants had difficulty using the app.
Given that 0% became frustrated, as reported by the RN,
and that 100% of participants completed the task, it was
clear to participants in the focus groups that the Signa-
ture App was not only understandable and usable by
almost anyone, but that it was in fact fun to use for
speedy and easy data entry.
Global experience
On a scale from 1 to 5, participants were asked to rate
their global experience with using the app. They checked
Table 3 Results by percentages
Dimensions AMD PD ER ALL
1- Attention in viewing video 85% 88% 66% 80%
(…xx% were attentive in viewing the video)
2- Feasibility of electronic signature 60% 55% 53% 56%
(…xx% had no difficulty with electronic signature)
3- Understanding the app 88% 90% 93% 90%
(…xx% had no difficulty with understanding the app)
4- Using the app 88% 98% 98% 97%
(…xx% had no difficulty with using the app)
4.1- Frustration 0% 0% 0% 0%
(…xx% got frustrated or became agitated)
4.2- Completion 100% 100% 100% 100%
(…xx% completed the questionnaire)
5- Global experience 86% 90% 87% 87%
(…xx% had a good experience with the app)
6- Maximal duration 62 m 55 m 51 m 56 m
(…xx minutes could be spent in completing questionnaires on an app)
7- Discussing the results 57% 62% 78% 66%
(…xx% would have liked to discuss the results)
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it'. Results were again presented to each focus group by
percentage with regards to the maximum possible total
for that group. There was very little difference between
the groups’ responses, with patients from the PD group
(90%) enjoying it 4% more than the AMD group (86%)
and 3% more than the ER group (87%). Study participants
were generally very satisfied, but one common concern
was about the BDI itself. Many would have liked to be able
to add their own answer when it was not among the
offered choices. The BDI does not allow that. Also, having
a function such as a text box that would appear after com-
pletion of each [or after all] responses would allow people
to note their impressions or comments, and might en-
hance participant’s interactive experience with the app.
Maximal duration
We wanted to know how much time service-users
thought their peers could dedicate to using an app to fill
out electronic forms. Some said “no more than 10 mi-
nutes,” others said “endlessly.” Some participants gave a
range, for example “45 minutes to an hour”. In such cases,
the higher figure in the range was used for data entry. The
longest time period given was 4 hours (240 minutes).
When the answer was “endlessly,” 240 minutes was used
for data entry.
The average for all 120 participants was 56 minutes
(Table 3). To focus group participants, it thus seemed rea-
sonable to expect future respondents to be able and wil-
ling to dedicate about an hour of their time. Participantsalso suggested, however, that there could be a great deal of
variability among users. People in acute distress might not
be able to remain focused for more than 15 minutes.
Therefore, one recommendation was to allow respondents
to choose, among different sets of questions, which ones
they would like to fill out first. Participants felt that future
respondents should be made comfortable to complete
only one set, if that was all they could do at that time, and
then as many as they could in their preferred order.
Discussing the results
This pilot-study evaluated only the Signature App per-
formance in administering electronic consent and ques-
tionnaires and the overall experience with the tablet, not
the Beck Depression Inventory in particular. Neverthe-
less, participants were asked if they would have liked to
discuss the results of the Beck Depression Inventory if
recorded. There was some variability among groups in a
range from 57% of AMD participants to 78% of ER par-
ticipants saying that they “would have liked” or “maybe
would have liked” to discuss the results. Some partici-
pants said that it would depend on whom they would be
discussing the results with, for example in identifying
topics of personal interest to be discussed with the
clinician.
ER participants were more inclined to discuss the re-
sults right away with their clinician, while being the least
attentive to viewing the video. There was a difference of
22% between the ER and PD groups with attention in
viewing the video and a difference of 21% between the
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ER focus group participants proposed the hypothesis that
the more a patient is in need of speaking to someone; the
less they would pay attention to a video. However, this
could also be true with information and consent paper
forms. ER patients would thus be more in need of inter-
action when in quest for emotional support.
When asked what the implication would be for the app
designers and developers, the ER focus group formulated
the recommendation of adding a function to the multi-
media app that would allow people to tell a bit of their
story before meeting their clinician. Participants were
aware that even so, it was possible that the clinician could
not have time to immediately discuss the specific issue(s)
some patients would like to raise but in the least, these pa-
tients could tell their story, and the clinician could listen
to these stories afterward. Some participants said it might
be very frustrating not to have this opportunity at all in
the ER. They recommended the addition of a question
about recent life events, a question that could be answered
verbally and audio-recorded: What brought you here? This
would also be a good way to optimize the multimedia bi-
directional capabilities of a mobile application.
Implementation of recommendations
In November 2012, the Signature Project was officially
launched at IUSMM, with Institutional Review Board ap-
proval. The Signature computational procedure and app
interface were specifically designed for maximum useful-
ness among populations suffering from cognitive deficits
and psychiatric disorders, a group that was included in the
R&D process of the Signature App. Literature underlines
the importance of actively involving users in the system
design process both to influence design and for the signifi-
cant cost-benefit advantages of such an approach, com-
pared to when targeted users test a new product only
when it is ready to be commercialized and that there is
too little room for improvements [25,26]. This pilot study
and contextual inquiry [27] aimed at gaining a better
understanding of participants’ preferences with regards to
the human-machine interaction and use of the app. Al-
most all patients’ recommendations that emanated from
the focus groups were addressed, as discussed below.
For this pilot-study, the PI and first author of this paper
appeared in the video to explain the electronic data collec-
tion process, research objectives, and the consent process.
Participants liked to hear and look at someone explaining
the project, but in focus group it was recommended to
provide information and consent paper form to whoever
would prefer to read (attention in viewing the video). As
recommended in focus groups, it was also decided to use
typical pen-paper consent form (feasibility of electronic
signature). Again as recommended, it is now possible to
change the size of the font displayed on the screen tofacilitate the reading of the questions (understanding and
using the app), but it is not yet possible to leave comments
for enhanced interactivity (global experience). Nor is it
possible, at present, for participants to choose the ques-
tionnaires they would prefer to complete first. They can,
however, stop at any time and their choice of answers is
kept for aggregation, even if each of the actual 168 ques-
tions are not all answered. Based on participant feedback,
it is anticipated the average time for completion of the
questions is one hour (maximal duration). Finally, at the
time of inauguration of the Signature Project, it was not
planned that patients would necessarily discuss their re-
sults of the questionnaires with their clinician, but they
will know, per the information and consent form, that
their clinician does have access to these results. It will
therefore be possible for patients to ask their clinician to
discuss the results of their participation with them. As
highlighted by Bauer and Moessner, the increasing avai-
lability of Information and Communication Technologies
has opened new perspectives for prevention, self-help and
treatment of mental disorders (“e-mental health”), as well
as within the context of regular face-to-face care [28]. This
study tends to support the view that the app can be used
to foster greater interactivity within a regular face-to-face
clinical encounter.
More than 25 years ago, Norman and Draper [29] em-
phasized the importance of having a good understanding of
the users’ expectations regarding a new technological prod-
uct, but without necessarily involving them actively in the
R&D process. Since then, active user participation through-
out the entire development process and throughout the
system lifecycle has become a constitutive characteristic of
user-centered systems design [30]. Redesigning an app to
match the expectations and values of psychiatric patients
involved more than feedback on the app’s colors and but-
tons: encompassed comments on the quality of the service
and how this app could be integrated into service delivery
and organizational processes [31,32]. Usually, new mobile
applications are designed to be used by professionals [5],
and with a predominately individual-based approach [33].
However, “individualized” does not equal “personalized.”
When an app is designed to be used by patients and when
patients are invited to give their input about the app’s
design and potential use, questioning how the app will im-
pact the person’s interaction with others (particularly clini-
cians) is necessary. An implication for developers of mobile
applications who seek input from psychiatric patients is
that they should be prepared to respond to potentially sen-
sitive questions, as participants may want to discuss matters
that go well beyond the mechanics needed to provide data.
For example, some patients with schizophrenia believe that
use of the Internet has the potential to favorably change
their relationships with doctors [19], and this could be the
case for mobile applications as well.
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The participation of psychiatric patients as active con-
tributors is part of the very foundation and history of
the Signature Project, having proven its utility in the
R&D process. Their input was sought and taken into
account. Still, a fully person-centered approach would
have included other stakeholders in the development of
the app, since clinical and interpersonal dynamics can be
affected by the introduction of the app in clinical practice.
For this reason, Progmet, Georgiou and Westbrook sug-
gested that implementers and adopters of such technolo-
gies should explicitly address questions about why and
how the mobility of these devices is expected to improve
care delivery and to support the work of clinicians [34].
Differences in interaction seem to predict adherence to
what would be agreed upon with a clinician [35]. There-
fore, an important limitation of this pilot-study is that
clinicians whose practice might be impacted were not as
involved in this pilot-study, from the onset, as were
patients. This could be corrected with a follow-up study
similar to this one with some IUSMM clinicians, as the
Signature App will continue to evolve from one iteration
to the next.
Another limitation is that only one questionnaire was
used in this study, the BDI, while several more will be
administered with the full Signature Project. It is pos-
sible that patients will not be as interested in discussing
results with their clinician after having spent an hour or
more with an app, compared to having spent only a few
minutes doing so, as was the case for this study. Also, as
its name indicates, the BDI is solely focused on depres-
sion, and this may limit the generalizability of findings.
It is possible that the results would differ for other types
or levels of psychological distress.
Conclusions
The use of electronic devices to answer psychiatric ques-
tionnaires is certainly not new, for example in the as-
sessment of anxiety [36,37]. What is new with this study
is that it provides insight into the added value of involv-
ing psychiatric patients early on as active contributors in
the development of a mobile application. This study
revealed that psychiatric patients can clearly manipulate
a tablet computer for data entry while waiting at a clinic
or even at the ER, and that this technology is appealing
to most of them. The active participation and input of
patients to this pilot-study were essential in making the
Signature Project data collection procedure and app a
positive, empowering and genuinely personalized expe-
rience. Participants’ recommendations were taken into
consideration to improve their experience of human-
computer interaction. Results of this pilot-study can sup-
port informed decisions about how to involve psychiatric
patients in the R&D of an app that would facilitate dataentry. More importantly, it suggests that an R&D process
should anticipate the clinical interaction in the assessment
of potential outcomes over the quality of mental health
care. In that respect, more participatory research is needed
by involving clinicians as well as patients in the R&D of an
app to be used by patients and providers through the cli-
nical encounter. Family members and other significant
others of patients could be involved too.
Many apps that are currently available do not have writ-
ten privacy policies [38]. This should soon cease to be the
case, as emerging certification standards now request such
policies, particularly in the medical field. Documentation
about how the content of an app was formulated should
also be provided to make sure that this content is reliable
[39]. As there can be several categories on a continuum of
possible levels and degrees of participation [40], among
those standards, we suggest that information should also
be provided about how and to what extent the targeted
users of an app, whether clinicians or patients, were in-
cluded in the R&D process of that app and interacted.
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